By expenditures
| Name | Title | Type |
|---|---|---|
| Clayton Anderson | SUPERINTENDENT | Auditee |
| Julie Davis | CHIEF FINANCE OFFICER | Auditee |
| Chad B. Atkinson | Partner | Auditee |
| Teri Gage | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 337882 | 2024 | 2025-01-14 | Eide Bailly LLP | $16.10M |
| 307955 | 2023 | 2024-06-03 | Eide Bailly LLP | $17.60M |
| 16478 | 2022 | 2022-12-15 | Hintonburdick PLLC | $16.11M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 337882 | 2024 | 2025-01-14 | 1095690 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 1095689 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 1095688 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 1095687 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 1095686 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 1095685 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 1095684 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 1095683 | 2024-005 | Significant Deficiency | - | G |
| 337882 | 2024 | 2025-01-14 | 1095682 | 2024-005 | Significant Deficiency | - | G |
| 337882 | 2024 | 2025-01-14 | 1095681 | 2024-003 | Significant Deficiency | - | L |
| 337882 | 2024 | 2025-01-14 | 519248 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 519247 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 519246 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 519245 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 519244 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 519243 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 519242 | 2024-004 | Significant Deficiency | Yes | I |
| 337882 | 2024 | 2025-01-14 | 519241 | 2024-005 | Significant Deficiency | - | G |
| 337882 | 2024 | 2025-01-14 | 519240 | 2024-005 | Significant Deficiency | - | G |
| 337882 | 2024 | 2025-01-14 | 519239 | 2024-003 | Significant Deficiency | - | L |
| 307955 | 2023 | 2024-06-03 | 976302 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976301 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976300 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976299 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976298 | 2023-003 | Material Weakness | - | AB |
| 307955 | 2023 | 2024-06-03 | 976297 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976296 | 2023-003 | Material Weakness | - | AB |
| 307955 | 2023 | 2024-06-03 | 976295 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976294 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976293 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 976292 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399860 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399859 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399858 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399857 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399856 | 2023-003 | Material Weakness | - | AB |
| 307955 | 2023 | 2024-06-03 | 399855 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399854 | 2023-003 | Material Weakness | - | AB |
| 307955 | 2023 | 2024-06-03 | 399853 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399852 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399851 | 2023-004 | Material Weakness | - | I |
| 307955 | 2023 | 2024-06-03 | 399850 | 2023-004 | Material Weakness | - | I |